• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.33% Nasdaq Up 0.03%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    173.93 Down 3.85(2.17%) 9:34AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:177.78
    Open:N/A
    Bid:174.10 x 300
    Ask:176.30 x 100
    1y Target Est:210.59
    Beta:1.45
    Next Earnings Date:29-Jan-15ALXN Earnings announcement
    Day's Range:172.36 - 174.00
    52wk Range:136.37 - 203.30
    Volume:92,316
    Avg Vol (3m):1,115,370
    Market Cap:34.49B
    P/E (ttm):72.35
    EPS (ttm):2.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALXN

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 2.17%34.49B
    AMGNUp 0.99%118.85B
    BAXUp 1.65%38.65B

    Key Statistics

    Forward P/E (1 yr):30.08
    P/S (ttm):16.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :5.20
    Quarterly EPS Est (Dec-14) :1.29
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback